常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-23.53/-0.31
|
|
企業價值
1.06B
|
| 資產負債 |
|
每股賬面淨值
13.56
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
542.34M
|
|
每股收益
5.59
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol. |

6.32 
